These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


159 related items for PubMed ID: 16377418

  • 1. Spinal cord planning risk volumes for intensity-modulated radiation therapy of head-and-neck cancer.
    Breen SL, Craig T, Bayley A, O'Sullivan B, Kim J, Jaffray D.
    Int J Radiat Oncol Biol Phys; 2006 Jan 01; 64(1):321-5. PubMed ID: 16377418
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Impact of patient setup error in the treatment of head and neck cancer with intensity modulated radiation therapy.
    Prabhakar R, Laviraj MA, Haresh KP, Julka PK, Rath GK.
    Phys Med; 2010 Jan 01; 26(1):26-33. PubMed ID: 19576833
    [Abstract] [Full Text] [Related]

  • 7. Dose sparing of brainstem and spinal cord for re-irradiating recurrent head and neck cancer with intensity-modulated radiotherapy.
    Chen CC, Lee CC, Mah D, Sharma R, Landau E, Garg M, Wu A.
    Med Dosim; 2011 Jan 01; 36(1):21-7. PubMed ID: 20202815
    [Abstract] [Full Text] [Related]

  • 8. Is there a "mucosa-sparing" benefit of IMRT for head-and-neck cancer?
    Sanguineti G, Endres EJ, Gunn BG, Parker B.
    Int J Radiat Oncol Biol Phys; 2006 Nov 01; 66(3):931-8. PubMed ID: 17011465
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy.
    Fiorino C, Dell'Oca I, Pierelli A, Broggi S, De Martin E, Di Muzio N, Longobardi B, Fazio F, Calandrino R.
    Radiother Oncol; 2006 Mar 01; 78(3):276-82. PubMed ID: 16546279
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A treatment planning analysis of inverse-planned and forward-planned intensity-modulated radiation therapy in nasopharyngeal carcinoma.
    Poon I, Xia P, Weinberg V, Sultanem K, Akazawa C, Akazawa P, Verhey L, Quivey JM, Lee N.
    Int J Radiat Oncol Biol Phys; 2007 Dec 01; 69(5):1625-33. PubMed ID: 18035216
    [Abstract] [Full Text] [Related]

  • 18. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
    Mavroidis P, Ferreira BC, Shi C, Lind BK, Papanikolaou N.
    Phys Med Biol; 2007 Jul 07; 52(13):3817-36. PubMed ID: 17664579
    [Abstract] [Full Text] [Related]

  • 19. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
    Søndergaard J, Høyer M, Petersen JB, Wright P, Grau C, Muren LP.
    Acta Oncol; 2009 Jul 07; 48(2):238-44. PubMed ID: 18759144
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.